Windlas Biotech Ltd
NSE:WINDLAS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
GHT Co Ltd
SZSE:300711
|
CN |
|
S
|
Sterling Infrastructure Inc
SWB:UAO
|
US |
|
Recticel NV
LSE:0NHV
|
BE |
|
Q
|
Qinqin Foodstuffs Group (Cayman) Company Ltd
HKEX:1583
|
CN |
|
S
|
ShenZhen YUTO Packaging Technology Co Ltd
SZSE:002831
|
CN |
|
M
|
MAG Holdings Berhad
KLSE:MAGNUM
|
MY |
|
G
|
Guangdong Huiyun Titanium Industry Co Ltd
SZSE:300891
|
CN |
|
F
|
Federal-Mogul Goetze (India) Ltd
NSE:FMGOETZE
|
IN |
Windlas Biotech Ltd
EPS (Diluted)
Windlas Biotech Ltd
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Windlas Biotech Ltd
NSE:WINDLAS
|
EPS (Diluted)
₹28
|
CAGR 3-Years
16%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
|
Divi's Laboratories Ltd
NSE:DIVISLAB
|
EPS (Diluted)
₹93
|
CAGR 3-Years
1%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
Syngene International Ltd
NSE:SYNGENE
|
EPS (Diluted)
₹8
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
5%
|
|
|
O
|
Onesource Specialty Pharma Ltd
NSE:ONESOURCE
|
EPS (Diluted)
-₹1
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sai Life Sciences Ltd
NSE:SAILIFE
|
EPS (Diluted)
₹8
|
CAGR 3-Years
206%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
A
|
Anthem Biosciences Ltd
NSE:ANTHEM
|
EPS (Diluted)
₹8
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Windlas Biotech Ltd
Glance View
Windlas Biotech Ltd. operates as a contract development and manufacturing organization (CDMO). The firm provides a range of contract development and manufacturing organization (CDMO) services ranging from product discovery, product development, licensing and commercial manufacturing of generic products, including complex generics. Its therapeutic categories, such as, anti-diabetic, cardiovascular, neuropsychiatry and respiratory therapies. The Company’s service capabilities include formulation development, technology scale-up and full-scale commercial manufacturing. The company has capabilities for both solid and liquid pharmaceutical dosage forms. The Company’s market its own manufactured nutraceutical, pharmaceutical and ayurvedic products to serve the semi-urban and rural communities. The company also has a salesforce and distribution network spread across over 14 states. The Company’s manufacturing facilities are located at Dehradun in Uttarakhand.
See Also
What is Windlas Biotech Ltd's EPS (Diluted)?
EPS (Diluted)
28.9
INR
Based on the financial report for Mar 31, 2025, Windlas Biotech Ltd's EPS (Diluted) amounts to 28.9 INR.
What is Windlas Biotech Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
31%
Over the last year, the EPS (Diluted) growth was 4%. The average annual EPS (Diluted) growth rates for Windlas Biotech Ltd have been 16% over the past three years , 31% over the past five years .
